Login / Signup

Early, biomarker-guided steroid dosing in COVID-19 Pneumonia: a pilot randomized controlled trial.

Yewande E OdeyemiSarah J ChalmersErin F BarretoJacob C JentzerOgnjen GajicHemang Yadav
Published in: Critical care (London, England) (2022)
ClinicalTrials.gov identifier (NCT number): NCT03852537 , Registered February 25, 2019.
Keyphrases
  • coronavirus disease
  • sars cov
  • open label
  • study protocol
  • double blind
  • respiratory syndrome coronavirus
  • randomized controlled trial
  • community acquired pneumonia
  • clinical trial